FRAMINGHAM, MA--(Marketwire - March 31, 2008) - Symbollon Pharmaceuticals, Inc. (OTCBB: SYMBA) today announced financial results for the year ended December 31, 2007. The Company reported a net loss of $(3,748,473), or $(0.29) per share, compared with a net loss of $(3,046,784), or $(0.36) per share, in the prior year.
